Vaccinia virus F16 protein, a predicted catalytically inactive member of the prokaryotic serine recombinase superfamily, is targeted to nucleoli

Virology

Volumn 417, Issue 2, 2011, Pages 334-342

  Senkevich, Tatiana G ^a   Koonin, Eugene V ^b   Moss, Bernard ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Poxvirus orthologs; Poxvirus prokaryotic homologs; Poxvirus recombinase; Vaccinia virus replication

Indexed keywords

PROTEIN F16; RECOMBINASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVE SITE; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOLUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN TARGETING; VACCINIA VIRUS; VIRUS MUTANT;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELL NUCLEOLUS; CERCOPITHECUS AETHIOPS; GENE KNOCKOUT TECHNIQUES; HUMANS; MOLECULAR SEQUENCE DATA; PLAQUE ASSAY; PROTEIN MULTIMERIZATION; RECOMBINASES; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; VACCINIA VIRUS; VIRAL LOAD; VIRAL PROTEINS; VIRUS REPLICATION;

AVES; POXVIRIDAE; PROKARYOTA; VACCINIA VIRUS;

EID: 80051948311     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.06.017     Document Type: Article

References (39)

1. Afonso C.L., Tulman E.R., Delhon G., Lu Z., Viljoen G.J., Wallace D.B., Kutish G.F., Rock D.L. Genome of crocodilepox virus. J. Virol. 2006, 80:4978-4991.
2. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25:3389-3402.
3. Altschul S.F., Wootton J.C., Gertz E.M., Agarwala R., Morgulis A., Schaffer A.A., Yu Y.K. Protein database searches using compositionally adjusted substitution matrices. FEBS J. 2005, 272:5101-5109.
4. Blanie S., Mortier J., Delverdier M., Bertagnoli S., Camus-Bouclainville C. M148R and M149R are two virulence factors for myxoma virus pathogenesis in the European rabbit. Vet. Res. 2009, 40:11.
5. Boisvert F.M., van Koningsbruggen S., Navascues J., Lamond A.I. The multifunctional nucleolus. Nat. Rev. Mol. Cell Biol. 2007, 8:574-585.
6. Buchan D.W., Ward S.M., Lobley A.E., Nugent T.C., Bryson K., Jones D.T. Protein annotation and modelling servers at University College London. Nucleic Acids Res. 2010, 38:W563-W568.
7. Bui M., Myers J.E., Whittaker G.R. Nucleo-cytoplasmic localization of influenza virus nucleoprotein depends on cell density and phosphorylation. Virus Res. 2002, 84:37-44.
8. Carroll M., Moss B. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line. Virology 1997, 238:198-211.
9. Chakrabarti S., Sisler J.R., Moss B. Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques 1997, 23:1094-1097.
10. Davison A.J., Moss B. The structure of vaccinia virus early promoters. J. Mol. Biol. 1989, 210:749-769.
11. Davison A.J., Moss B. The structure of vaccinia virus late promoters. J. Mol. Biol. 1989, 210:771-784.
12. Earl P.L., Cooper N., Wyatt L.S., Moss B., Carroll M.W. Preparation of cell cultures and vaccinia virus stocks. Current Protocols in Molecular Biology 1998, Vol. 2:16.16.1-16.16.3. John Wiley and Sons, New York. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, K. Struhl (Eds.).
13. Earl P.L., Moss B., Wyatt L.S., Carroll M.W. Generation of recombinant vaccinia viruses. Current Protocols in Molecular Biology 1998, Vol. 2:16.17.1-16.17.19. Greene Publishing Associates & Wiley Interscience, New York. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, K. Struhl (Eds.).
14. Emmott E., Hiscox J.A. Nucleolar targeting: the hub of the matter. EMBO Rep. 2009, 10:231-238.
15. Garcia A.D., Aravind L., Koonin E.V., Moss B. Bacterial-type DNA Holliday junction resolvases in eukaryotic viruses. Proc. Natl Acad. Sci. U. S. A. 2000, 97:8926-8931.
16. Grindley N.D., Whiteson K.L., Rice P.A. Mechanisms of site-specific recombination. Annu. Rev. Biochem. 2006, 75:567-605.
17. Hiscox J.A. RNA viruses: hijacking the dynamic nucleolus. Nat. Rev. Microbiol. 2007, 5:119-127.
18. Hiscox J.A., Whitehouse A., Matthews D.A. Nucleolar proteomics and viral infection. Proteomics 2010, 10:4077-4086.
19. Jao C.Y., Salic A. Exploring RNA transcription and turnover in vivo by using click chemistry. Proc. Natl Acad. Sci. U. S. A. 2008, 105:15779-15784.
20. Jefferts E.R., Holowczak RNA synthesis in vaccinia-infected L cells: inhibition of ribosome formation and maturation. Virology 1971, 46:730-744.
21. Katoh K., Kuma K., Toh H., Miyata T. MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. 2005, 33:511-518.
22. Katsafanas G.C., Moss B. Colocalization of transcription and translation within cytoplasmic poxvirus factories coordinates viral expression and subjugates host functions. Cell Host Microbe 2007, 2:221-228.
23. Koonin E.V., Yutin N. Origin and evolution of eukaryotic large nucleo-cytoplasmic DNA viruses. Intervirology 2010, 53:284-292.
24. McGuffin L.J., Bryson K., Jones D.T. The PSIPRED protein structure prediction server. Bioinformatics 2000, 16:404-405.
25. Moss B. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc. Natl Acad. Sci. U. S. A. 1996, 93:11341-11348.
26. Moss B. Poxviridae: the viruses and their replication. Fields Virology 2007, Vol. 2:2905-2946. Lippincott Williams & Wilkins, Philadelphia, 2 vols. D.M. Knipe, P.M. Howley (Eds.).
27. Olorunniji F.J., Stark W.M. The catalytic residues of Tn3 resolvase. Nucleic Acids Res. 2009, 37:7590-7602.
28. Olorunniji F.J., Stark W.M. Catalysis of site-specific recombination by Tn3 resolvase. Biochem. Soc. Trans. 2010, 38:417-421.
29. Paran N., De Silva F.S., Senkevich T.G., Moss B. Cellular DNA ligase I is recruited to cytoplasmic vaccinia virus factories and masks the role of the vaccinia ligase in viral DNA replication. Cell Host Microbe 2009, 6:563-569.
30. Parrish S., Resch W., Moss B. Vaccinia virus D10 protein has mRNA decapping activity, providing a mechanism for control of host and viral gene expression. Proc. Natl Acad. Sci. U. S. A. 2007, 104:2139-2144.
31. Puckett C., Moss B. Selective transcription of vaccinia virus genes in template dependent soluble extracts of infected cells. Cell 1983, 35:441-448.
32. Salsman J., Zimmerman N., Chen T., Domagala M., Frappier L. Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies. PLoS Pathog. 2008, 4:e1000100.
33. Senkevich T.G., Wyatt L.S., Weisberg A.S., Koonin E.V., Moss B. A conserved poxvirus NlpC/P60 superfamily protein contributes to vaccinia virus virulence in mice but not to replication in cell culture. Virology 2008, 374:506-514.
34. Sirri V., Urcuqui-Inchima S., Roussel P., Hernandez-Verdun D. Nucleolus: the fascinating nuclear body. Histochem. Cell Biol. 2008, 129:13-31.
35. Smith M.C., Thorpe H.M. Diversity in the serine recombinases. Mol. Microbiol. 2002, 44:299-307.
36. Soding J. Protein homology detection by HMM-HMM comparison. Bioinformatics 2005, 21:951-960.
37. Taliansky M.E., Brown J.W., Rajamaki M.L., Valkonen J.P., Kalinina N.O. Involvement of the plant nucleolus in virus and viroid infections: parallels with animal pathosystems. Adv. Virus Res. 2010, 77:119-158.
38. Upton C., Slack S., Hunter A.L., Ehlers A., Roper R.L. Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome. J. Virol. 2003, 77:7590-7600.
39. Yuwen H., Cox J.H., Yewdell J.W., Bennink J.R., Moss B. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3l gene. Virology 1993, 195:732-744.